Sum composition results

AbbreviationFormulaMassMain ClassSub Class
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 34:1;O2C58H107NO211153.733566Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 36:1;O2C60H111NO211181.764866Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 38:1;O2C62H115NO211209.796166Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2C60H110N2O231226.749944Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 40:1;O2C64H119NO211237.827466Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2C62H114N2O231254.781245Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 42:2;O2C66H121NO211263.843116Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 42:1;O2C66H123NO211265.858766Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2C64H118N2O231282.812545Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 44:2;O2C68H125NO211291.874416Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 44:1;O2C68H127NO211293.890066Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2C66H122N2O231310.843845Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:2;O2C68H124N2O231336.859495Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:1;O2C68H126N2O231338.875145Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:2;O2C70H128N2O231364.890795Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:1;O2C70H130N2O231366.906445Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2C66H120N2O281388.802770Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2C68H124N2O281416.834070Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 34:1;O2C68H123N3O281429.829318Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2C68H123N3O281429.829318Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2C70H128N2O281444.865370Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 36:1;O2C70H127N3O281457.860618Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2C70H127N3O281457.860618Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2C72H132N2O281472.896670Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 38:1;O2C72H131N3O281485.891919Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2C72H131N3O281485.891919Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:2;O2C74H134N2O281498.912320Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:1;O2C74H136N2O281500.927970Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 40:1;O2C74H135N3O281513.923219Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2C74H135N3O281513.923219Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:2;O2C76H138N2O281526.943620Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:1;O2C76H140N2O281528.959270Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 42:2;O2C76H137N3O281539.938869Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:2;O2C76H137N3O281539.938869Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 42:1;O2C76H139N3O281541.954519Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:1;O2C76H139N3O281541.954519Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 44:2;O2C78H141N3O281567.970169Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:2;O2C78H141N3O281567.970169Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 44:1;O2C78H143N3O281569.985819Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:1;O2C78H143N3O281569.985819Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(GalNAcβ1-4Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2C74H133N3O331591.882144Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcβ1-3Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2C74H133N3O331591.882144Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(GalNAcβ1-4Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2C76H137N3O331619.913444Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcβ1-3Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2C76H137N3O331619.913444Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcα1-3GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2C76H136N4O331632.908692Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(GalNAcβ1-4Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2C78H141N3O331647.944744Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcβ1-3Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2C78H141N3O331647.944744Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcα1-3GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2C78H140N4O331660.939992Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
Galα1-3(GalNAcβ1-4Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2C80H145N3O331675.976044Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
GalNAcβ1-3Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2C80H145N3O331675.976044Neutral glycosphingolipids [SP05]Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]

Showing page 1 of 2     Results:    1  2  Next     Showing results 1 to 50 of 88